BioSpace News Archive

Allogene Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) to ALLO-605, the Company’s next-generation AlloCAR T product candidate targeting BCMA for the treatment of multiple myeloma.

Tempest Therapeutics, Inc. announced a $15 million private investment in public equity financing from the sale of 3,149,912 shares of its common stock at a price per share of $2.36 and, in lieu of shares of common stock, pre-funded warrants to purchase up to 3,206,020 shares of its common stock at price per pre-funded warrant of $2.359 to EcoR1 Capital, LLC and Versant Venture Capital.

ContraFect Corporation announces presentation data showing DLA CF-370 is highly efficacious in a rabbit pneumonia model of a particularly hard-to-treat, extensively-drug-resistant strain of Pseudomonas aeruginosa, and also has the ability to both avoid antimicrobial resistance and suppress antibiotic resistance to commonly-used antibiotics in vitro.

IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its first quarter 2022 financial and operating results on Wednesday, May 4, 2022.

Comera Life Sciences, Inc. today announced that Robert P. Mahoney, Ph.D., Chief Scientific Officer, will present at the PEGS Boston Conference & Expo, being held May 2-6, 2022, in-person.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, May 5, 2022 to report financial results for the quarter ended March 31, 2022 and discuss recent corporate highlights.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked fifth in overall corporate reputation among patient groups that have worked directly with the company and seventh among patient groups who were familiar with the company.

Albany NY, United States: Transparency Market Research has ublished a new report titled, “Dermal Fillers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Rise in use of augmented reality in the healthcare sector for various activities such as surgical simulation, diagnostic imaging, patient care management, and rehabilitation is boosting the sales opportunities in the global AR in healthcare market.

The global rehabilitation equipment market is expected to expand at a CAGR of 5.2% during the forecast period of 2020 to 2025.